Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Research Award: Canada Graduate Scholarships

McGill University

$105,000.00

Elucidating the role of bacteriophage infection in ulcerative colitis

FY 2019-20

Summary
Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) of the human gut that has a great impact on the health of patients and the overall costs of health care in Canada. Currently there is no cure for UC, however, it is thought that the trillions of bacteria that live in the human gut might contribute to the disease. During UC, there is an imbalance in the types of bacteria that exist in the gut. Viruses that infect these bacteria, known as bacteriophages (phages), are present at equal numbers to bacteria in the gut and also seem to be imbalanced during UC. In other ecosystems, phages have been shown to infect bacteria and change the types of bacteria that exist in these systems. It is possible that these phages could be used for therapy in UC by preventing the imbalance of bacteria that occurs in these diseases. However, we first need to understand how these viruses infect and interact with bacteria in the gut during UC. We plan to characterize how phages from UC patients infect bacteria in the gut. In order to investigate this question, we first plan to give phages from either healthy volunteers or UC patients to mice and follow how the number, and activity of bacteria changes in the gut of these mice. Using DNA sequencing of bacteria, we will determine how the addition of UC phages to these mice might change the composition of bacteria to a state that might promote inflammation and disease. Finally, we will characterize which specific phages infect which bacteria in UC patients and healthy volunteers by tracking phages with a fluorescent dye and then performing DNA sequencing on both the phages and bacteria. Collectively, our approach will provide insight into how phage infection of bacteria might be changed during UC. It is possible that our data could help develop future therapeutics focused on using phages to change bacterial communities in UC patients.
Program
Doctoral Research Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
416928
Name
Sinha Anshul A
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Elucidating the role of bacteriophage infection in ulcerative colitis
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Bacteriophages; Chronic Inflammation; Flow Cytometry; Gastrointestinal Tract; Gnotobiotic Mouse Model; Gut Microbiome; Inflammatory Bowel Disease; Metagenomics
Abstract
Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) of the human gut that has a great impact on the health of patients and the overall costs of health care in Canada. Currently there is no cure for UC, however, it is thought that the trillions of bacteria that live in the human gut might contribute to the disease. During UC, there is an imbalance in the types of bacteria that exist in the gut. Viruses that infect these bacteria, known as bacteriophages (phages), are present at equal numbers to bacteria in the gut and also seem to be imbalanced during UC. In other ecosystems, phages have been shown to infect bacteria and change the types of bacteria that exist in these systems. It is possible that these phages could be used for therapy in UC by preventing the imbalance of bacteria that occurs in these diseases. However, we first need to understand how these viruses infect and interact with bacteria in the gut during UC. We plan to characterize how phages from UC patients infect bacteria in the gut. In order to investigate this question, we first plan to give phages from either healthy volunteers or UC patients to mice and follow how the number, and activity of bacteria changes in the gut of these mice. Using DNA sequencing of bacteria, we will determine how the addition of UC phages to these mice might change the composition of bacteria to a state that might promote inflammation and disease. Finally, we will characterize which specific phages infect which bacteria in UC patients and healthy volunteers by tracking phages with a fluorescent dye and then performing DNA sequencing on both the phages and bacteria. Collectively, our approach will provide insight into how phage infection of bacteria might be changed during UC. It is possible that our data could help develop future therapeutics focused on using phages to change bacterial communities in UC patients.
Competitiondate
201911
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Sinha, Anshul A
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~
McGill University - $105,000 Grant (2019-20) | Canada Spends